Celon Pharma is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The Company is also marketing authorisation holder for its products. It invests in the development of innovative pharmaceutical products which have the potential to treat cancers, neurological diseases, diabetes and other metabolic disorders. Celon Pharma has obtained financial resources for research into new drugs from the sale of generic drugs, as well as from the EU funds obtained under the Innovative Economy programme.